Skip to main content

This job has expired

You will need to login before you can apply for a job.

IP Liaison

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Oct 5, 2022

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How you will Achieve More with Intellia:

As an Intellectual Property Liaison, you will partner with researchers and legal professionals in the creation, management, and protection of intellectual property assets. To achieve therapeutic and business goals, Intellia’s technology platform uses biotechnologies spanning fields such as nucleic acid chemistry, lipid nanoparticles, molecular biology, gene editing, protein engineering, immunology, and computer science, among others. You will provide technological understanding to IP analysis, maintain close interactions with R&D, and function as a project manager for complex scientific-legal projects. Additional role responsibilities include but are not limited to:

  • Build and manage relationships with internal researchers to understand new innovations, monitor technical progress, and provide IP education

  • Analyze and interpret technical information to assess IP needs and to support patent application drafting and execution

  • Coordinate technical writing of experiments for patent applications

  • Provide project management support to patent application and IP analysis projects

  • Assist in drafting, filing, and prosecuting patent applications

  • Review technical disclosures and proposed publications to identify confidential, proprietary, and/or patentable subject matter

  • Search literature and patent databases to identify and analyze relevant prior art references

About You:

You have strong scientific credentials, excellent writing and communication skills, practical critical-thinking skills, and the desire and ability to work across various biotechnologies. If you consider yourself a team player, critical thinker, and a problem solver, then we encourage you to apply! The position offers extensive professional development and mentor support in a team culture, as well as the opportunity to prepare for the USPTO exam. Additional role requirements include:

  • Bachelor’s degree or higher from an accredited college or university required, preferably in chemistry, biology, medicine, pharmacology, or other relevant sciences

  • Scientific research experience from or comparable to a Masters or PhD in a biotechnology-related field such as chemistry, biology, medicine, pharmacology, or other relevant areas

  • Experience managing multiple projects at the same time including excellent organizational skills and adeptness at prioritizing tasks

  • Word processing and spreadsheet skills relevant to Microsoft Office programs (Word, Outlook, and Excel) and ability to learn new software

  • Familiarity with patents and intellectual property is a plus

Meet your future team:

This role reports to the Director of Intellectual Property, Head of IP Liaisons and works with other members of the IP Team as well as with research professionals and outside counsel. The IP Team is a hard working, highly collaborative team staffed by individuals who value and support each other. The team functions on a hybrid remote/on-site model that allows for flexibility while fostering a strong sense of community within the team and with stakeholders.

There is no road map for what we are doing as leaders in the systemic delivery of in vivo CRISPR-Cas9 therapies, while offering a full spectrum approach to create CRISPR-Cas9 therapy via our ex vivo pipeline. We thrive on charting new territory, exploring new ways to drive our programs and the business forward. We are cultivating the culture of ONE, EXPLORE, DISRUPT, and DELIVER that has made, and continues to make, Intellia such an incredible place to work.

Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert